Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy. VER [Internet]. 2025 Nov. 18 [cited 2026 Apr. 8];8(10s):203-16. Available from: https://verjournal.com/index.php/ver/article/view/812